Feedback / Questions
Undisclosed MC4R agonist - Superluminal Medicines
https://www.prnewswire.com/news-releases/superluminal-medicines-announces-a-selective-biased-mc4r-agonist-is-advancing-to-ind-enabling-studies-for-the-treatment-of-obesity-302510239.html
 
Jul 22, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious